Viewing Study NCT03769168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2026-06-13 @ 7:55 PM
Study NCT ID: NCT03769168
Status: COMPLETED
Last Update Posted: 2025-10-16
First Post: 2018-11-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Juvenile Psoriatic Arthritis View
None Enthesitis Related Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None JIA View
None JPsA View
None ERA View
None Secukinumab View
None ILAR View
None Juvenile Psoriatic Arthritis View
None Enthesitis Related Arthritis View